NORTHWEST BIOTHERAPEUTICS INC
SEC Filing List
NWBO CIK: 0001072379
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 04/07/2026 | |
| NT 10-K | Notice under Rule 12b25 of inability to ... | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 03/31/2026 | |
| 8-K | Current report filing | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 01/15/2026 | |
| 8-K | Current report filing | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 01/02/2026 | |
| DEF 14A | Definitive proxy statements | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 11/28/2025 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 11/25/2025 | |
| EFFECT | Effectiveness refer to a Registration St... | cik 9999999995 /fa | 11/25/2025 | ||
| CORRESP | A correspondence can be sent as a docume... | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 11/24/2025 | |
| 8-K | Current report filing | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 11/20/2025 | |
| PRE 14A | Preliminary proxy statement not related ... | Northwest Biotherapeutics Inc | Toppan Merrill/FA | 11/19/2025 | |
| No record found. | |||||
| Load More | |||||
